Telerehabilitation Approaches in Chronic Obstructive Pulmonary Patients

Saglik Bilimleri Universitesi

Status: Unknown

Conditions: Telerehabilitation; COPD

Treatments: Other: videoconference-based; Other: video-based

Study type: Interventional

Funder types: Other

Identifiers

NCT04694729

TeleCOPD

Details and patient eligibility

About

Pulmonary rehabilitation (PR) is a first-line management strategy in chronic obstructive pulmonary patients (COPD) as it reduces shortness of breath, increases exercise capacity, and improves health-related quality of life. However, 8-50% of patients referred to PR do not participate at all, while 10-32% of those who start do not complete the program. Barriers to participation and completion include difficulty in accessing the program, poor mobility, lack of transport, and travel costs. Telerehabilitation is defined as the provision of rehabilitation services through telecommunication technology, including telephone, internet and video conference communications between the patient and the healthcare provider. Different technologies (from phone to video conferencing) have been tested in patients with COPD to enhance daily activities, exercise training and walking prescription. All of them showed positive effects on exercise tolerance, dyspnea, physical activity and quality of life. However, there is no study about which telerehabilitation program is more effective on COPD patients. The aim of this study is to investigate which telerehabilitation approach is more effective in COPD.

Enrollment: 54 estimated patients

Sex: All

Ages: 18+ years old

Volunteers: Accepts Healthy Volunteers

Inclusion criteria

• Being diagnosed with COPD (FEV1 / FVC <70% in the stable phase of the disease)
• Age > 18 years old
• Have the ability to use a smartphone

Exclusion criteria

• Musculoskeletal disorders that limit exercise
• Dizziness, significant sensory or motor impairments, dementia or terminal illnesses that prevent education
• Serious comorbidities such as unstable heart disease, irregular diabetes, known malignant disease, any other disease that makes the patient unsuitable for participation in the study.
• Incompatible patient
• Severe vision or hearing impairment
• Unwillingness or inability to follow the protocol
• Have had a COPD exacerbation in the previous 6 weeks

Trial design

Primary purpose: Treatment

Allocation: Randomized

Interventional model: Parallel Assignment

Masking: None (Open label)

---

54 participants in 2 patient groups

study group

Experimental group

Description:

Videoconference-based

Treatment:

Other: videoconference-based

control group

Experimental group

Description:

Video-based

Treatment:

Other: video-based